FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2027275558> ?p ?o ?g. }

• W2027275558 endingPage "1173" @default.
• W2027275558 startingPage "1173" @default.
• W2027275558 abstract "We recently reported the results of a controlled trial conducted between June 1996 and December 1998 comparing a 3-day quinine-clindamycin (QC) regimen (53 patients) with a 7-day Q regimen (55 patients) for treating uncomplicated Plasmodium falciparum malaria in returned travelers (1). There was no significant difference between these regimens with regard to the 28-day cure rate and parasite and fever clearance times. Furthermore, we noted a trend towards a better tolerance of the QC regimen (1).Between January 1999 and December 2001, a total of 123 more patients with uncomplicated falciparum malaria received the previously studied 3-day treatment with intravenous QC (with Q at 8 mg/kg of body weight every 8 h and C at 5 mg/kg every 8 h). Patients had returned from areas in sub-Saharan Africa where malaria is endemic. During the treatment, 12 (9.8%) patients presented with minor side effects, including transient hypoacusis (4%), nausea (3.2%), transient hypoglycemia (1%), anxiety (0.8%), diarrhea (0.8%), and transient rash (0.8%). The treatment was stopped for two patients on day 2 because one had severe diarrhea and the other had intense abdominal pain. In both of these cases, the C was stopped and the patients completed therapy with a 7-day Q regimen and remained well. Bacteriological analyses of the feces, including a test for Clostridium difficile, were negative. When discharged on day 4, all 121 patients who completed the 3-day treatment were afebrile, and thick blood smears were negative in all cases. Thereafter, follow-up included physical examination and analysis of thick blood smears prepared during visits in our outpatient department on days 7 (74.4% of patients returned), 14 (61.1% returned), and 28 (40.5% returned). One patient had positive thick blood smears (parasitemia, <0.1%) on day 14 without any fever. He did not receive any treatment. He remained afebrile, and a thick blood smear on day 28 was negative. A second patient presented on day 14 with a positive blood smear that had been prepared and analyzed in a private laboratory (parasitemia, <0.1%). Although he had no fever, he treated himself with oral mefloquine before coming to the visit. This patient was excluded from the analysis. He remained well. All other patients seen at the follow-up visits presented with no fever, and their thick blood smears were negative. Concerning the patients who did not complete the follow-up procedure, all except two were reached by phone. None had a febrile illness or had been hospitalized for malaria recrudescence in the 6 months following the QC treatment. In summary, out of the 123 patients who received the QC treatment, 122 were included in the analysis and 1 was excluded. In the per-protocol analysis, 120 of 122 patients (98.4%) were considered successfully treated with the 3-day QC regimen. In the intention-to-treat analysis, 118 of 122 (96.7%) were considered successfully treated.We report here the results for the largest series of returned travelers with uncomplicated falciparum malaria treated with a 3-day QC combination. The data were obtained through an open protocol. However, 98.4% of the patients could be evaluated after a 6-month period by clinical and parasitological follow-up or by phone. The present data extend the results from our previous randomized study and confirm that a 3-day intravenous QC regimen for treating imported uncomplicated P. falciparum malaria in returned travelers is well tolerated and can be proposed as a first-line treatment regimen for imported uncomplicated falciparum malaria. The benefit includes the reduction of the duration of the Q treatment and its side effects.In our unit, around 30% of patients with uncomplicated malaria present with vomiting. Thus, intravenous treatment is often required. Both Q and C may be given by this route, and the combination may be as effective in oral treatment (in the absence of vomiting). As it is preferable that therapy of uncomplicated malaria be oral, a pilot study comparing 3-day oral QC treatment to mefloquine treatment has just started in our unit." @default.
• W2027275558 created "2016-06-24" @default.
• W2027275558 creator A5002266644 @default.
• W2027275558 creator A5009185459 @default.
• W2027275558 creator A5017122493 @default.
• W2027275558 creator A5020692401 @default.
• W2027275558 creator A5061281389 @default.
• W2027275558 creator A5073660904 @default.
• W2027275558 creator A5082174201 @default.
• W2027275558 date "2003-03-01" @default.
• W2027275558 modified "2023-10-15" @default.
• W2027275558 title "Three-Day Quinine-Clindamycin Treatment of Uncomplicated Falciparum Malaria Imported from the Tropics" @default.
• W2027275558 cites W2134992609 @default.
• W2027275558 doi "https://doi.org/10.1128/aac.47.3.1173.2003" @default.
• W2027275558 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/149314" @default.
• W2027275558 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12604566" @default.
• W2027275558 hasPublicationYear "2003" @default.
• W2027275558 type Work @default.
• W2027275558 sameAs 2027275558 @default.
• W2027275558 citedByCount "14" @default.
• W2027275558 countsByYear W20272755582012 @default.
• W2027275558 countsByYear W20272755582016 @default.
• W2027275558 countsByYear W20272755582019 @default.
• W2027275558 crossrefType "journal-article" @default.
• W2027275558 hasAuthorship W2027275558A5002266644 @default.
• W2027275558 hasAuthorship W2027275558A5009185459 @default.
• W2027275558 hasAuthorship W2027275558A5017122493 @default.
• W2027275558 hasAuthorship W2027275558A5020692401 @default.
• W2027275558 hasAuthorship W2027275558A5061281389 @default.
• W2027275558 hasAuthorship W2027275558A5073660904 @default.
• W2027275558 hasAuthorship W2027275558A5082174201 @default.
• W2027275558 hasBestOaLocation W20272755582 @default.
• W2027275558 hasConcept C138885662 @default.
• W2027275558 hasConcept C15708023 @default.
• W2027275558 hasConcept C18903297 @default.
• W2027275558 hasConcept C203014093 @default.
• W2027275558 hasConcept C2777458120 @default.
• W2027275558 hasConcept C2777617192 @default.
• W2027275558 hasConcept C2778048844 @default.
• W2027275558 hasConcept C2778371730 @default.
• W2027275558 hasConcept C3017884845 @default.
• W2027275558 hasConcept C501593827 @default.
• W2027275558 hasConcept C50660011 @default.
• W2027275558 hasConcept C71924100 @default.
• W2027275558 hasConcept C86803240 @default.
• W2027275558 hasConcept C89423630 @default.
• W2027275558 hasConceptScore W2027275558C138885662 @default.
• W2027275558 hasConceptScore W2027275558C15708023 @default.
• W2027275558 hasConceptScore W2027275558C18903297 @default.
• W2027275558 hasConceptScore W2027275558C203014093 @default.
• W2027275558 hasConceptScore W2027275558C2777458120 @default.
• W2027275558 hasConceptScore W2027275558C2777617192 @default.
• W2027275558 hasConceptScore W2027275558C2778048844 @default.
• W2027275558 hasConceptScore W2027275558C2778371730 @default.
• W2027275558 hasConceptScore W2027275558C3017884845 @default.
• W2027275558 hasConceptScore W2027275558C501593827 @default.
• W2027275558 hasConceptScore W2027275558C50660011 @default.
• W2027275558 hasConceptScore W2027275558C71924100 @default.
• W2027275558 hasConceptScore W2027275558C86803240 @default.
• W2027275558 hasConceptScore W2027275558C89423630 @default.
• W2027275558 hasIssue "3" @default.
• W2027275558 hasLocation W20272755581 @default.
• W2027275558 hasLocation W20272755582 @default.
• W2027275558 hasLocation W20272755583 @default.
• W2027275558 hasOpenAccess W2027275558 @default.
• W2027275558 hasPrimaryLocation W20272755581 @default.
• W2027275558 hasRelatedWork W2097080295 @default.
• W2027275558 hasRelatedWork W2331529029 @default.
• W2027275558 hasRelatedWork W2336354519 @default.
• W2027275558 hasRelatedWork W2395507910 @default.
• W2027275558 hasRelatedWork W2416979580 @default.
• W2027275558 hasRelatedWork W2417057423 @default.
• W2027275558 hasRelatedWork W2418438964 @default.
• W2027275558 hasRelatedWork W2802813266 @default.
• W2027275558 hasRelatedWork W3090222077 @default.
• W2027275558 hasRelatedWork W2142852603 @default.
• W2027275558 hasVolume "47" @default.
• W2027275558 isParatext "false" @default.
• W2027275558 isRetracted "false" @default.
• W2027275558 magId "2027275558" @default.
• W2027275558 workType "article" @default.